Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOITBE II: Stereotactic Puncture + rt-PA for Basal Ganglia Hemorrhage
NCT04172376Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in basal ganglia hemorrhage (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Change of Activities of Daily Living Score at 6 months. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
basal ganglia hemorrhage
Beyond the preview
Go deeper on NCT04172376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04172376.